7ACC2: Carboxycoumarin MCT1 Inhibitor for Cancer Metaboli...
2025-10-19
7ACC2 redefines cancer metabolism research by offering precise, dual inhibition of monocarboxylate transporter 1 (MCT1) and mitochondrial pyruvate transport. Its high potency and unique mechanistic profile enable advanced workflows for dissecting lactate uptake, immunometabolic crosstalk, and radiosensitization in tumor models.